While the pharmaceutical industry has mainly focused on developing antiviral drugs that can fight off coronavirus infections and vaccines, one biotech firm is working on a treatment that would protect a patient's lungs from COVID-19's worst effects, Stat News reports.
Scientists now have a clear sense that the virus enters a person's system through ACE2, an enzyme commonly found on the surface of lung cells. One of ACE2's jobs is to prevent inflammation, but when it's interrupted (as it is in coronavirus patients), it can no longer keep a peptide that constricts blood vessels, known as angiotensin II, in check. Normally, ACE2 would fend off angiotensin II by converting it to angiotensin-(1-7), another peptide that relaxes the vessels and reduces inflammation, protecting people from blood clots and oxidation, which some COVID-19 patients have suffered from.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
'Is the death penalty racist? Of course it is.'Instant Opinion Opinion, comment and editorials of the day
-
Today's political cartoons - May 8, 2024Cartoons Wednesday's cartoons - social media guilt, gag orders, and more
-
Boy Scouts changes name to Scouting AmericaSpeed Read The organization is rebranding, citing inclusivity
-
Blind people will listen to next week's total eclipseSpeed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
-
Melting polar ice is messing with global timekeepingSpeed Read Ice loss caused by climate change is slowing the Earth's rotation
-
An amphibian that produces milk?speed read Caecilians, worm-like amphibians that live underground, produce a milk-like substance for their hatchlings
-
Jupiter's Europa has less oxygen than hopedspeed read Scientists say this makes it less likely that Jupiter's moon harbors life
-
Why February 29 is a leap daySpeed Read It all started with Julius Caesar
-
US spacecraft nearing first private lunar landingSpeed Read If touchdown is successful, it will be the first U.S. mission to the moon since 1972
-
Scientists create 'meaty' rice for eco-friendly proteinSpeed Read Korean scientists have invented a new hybrid food, consisting of beef muscle and fat cells grown inside grains of rice
-
New images reveal Neptune and Uranus in different colours than originally thoughtSpeed Read Voyager 2 images from the 1980s led to 'modern misconception'
